Followers | 63 |
Posts | 25705 |
Boards Moderated | 0 |
Alias Born | 11/23/2016 |

Thursday, March 13, 2025 7:26:20 AM
63% insty ownership and more increased than decreased positions - not that the 'smart' WS guys always get it right...
The longer we wait, the sooner we will get rich!
Recent ALDX News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/25/2025 08:28:50 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/25/2025 08:25:44 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/25/2025 08:19:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/18/2025 08:41:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2025 08:01:40 PM
- Aldeyra Therapeutics Appoints Chip Clark to Board of Directors • Business Wire • 04/17/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2025 08:50:12 PM
- BFA Law Announces an Investigation into Aldeyra Therapeutics, Inc. 75% Stock Drop; Investors are Notified to Contact BFA Law • Business Wire • 04/03/2025 04:34:00 PM
- Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease • Business Wire • 04/03/2025 12:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/28/2025 09:19:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:17:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:13:41 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/28/2025 10:03:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2025 09:36:59 PM
- Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference • Business Wire • 02/04/2025 12:00:00 PM
- Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference • Business Wire • 12/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 12:01:10 PM
- Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement • Business Wire • 11/18/2024 12:00:00 PM
- Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference • Business Wire • 11/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:02:05 PM
- Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting • Business Wire • 10/31/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2024 12:22:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 11:01:12 AM
- Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease • Business Wire • 10/03/2024 11:00:00 AM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • INND • Apr 24, 2025 8:00 AM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM